Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
04/2010
04/14/2010CN101693103A Improvement of completeness of intestinal barrier
04/14/2010CN101693013A Ginseng stem leaf saponin granule for beasts and birds and preparation method thereof
04/13/2010US7696403 Drug screening for an allergosis; screening an inducer/promoter or an inhibitor for Th2-mediated immune response or a promoter or an inhibitor for PIR-A function
04/13/2010US7696317 Mammalian genes; related reagents and methods
04/13/2010US7696314 Hypoallergenic mutant polypeptides based on fish parvalbumin
04/13/2010US7696184 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
04/13/2010US7696181 Partial and full agonists of A1 adenosine receptors
04/13/2010US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder
04/13/2010US7696157 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression
04/13/2010US7696156 Human hemojuvelin (HJV) or dragon-like 1 (DL-1) polypeptides and variants and uses thereof
04/13/2010US7696155 Hemojuvelin or dragon-like 2 (DL-2) polypeptides and variants and uses thereof
04/13/2010US7695940 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
04/13/2010US7695939 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
04/13/2010CA2449747C Use of fkbp chaperones as expression tool
04/13/2010CA2443802C Pyrazolo[1,5-a]pyridines and medicines containing the same
04/13/2010CA2432303C Pyrazole compounds useful as protein kinase inhibitors
04/13/2010CA2430363C Compounds and their uses
04/13/2010CA2422377C Pyrazole compounds useful as protein kinase inhibitors
04/13/2010CA2399208C Nucleoside analogs with carboxamidine modified monocyclic base
04/13/2010CA2360680C Antioxidant compositions and methods for companion animals
04/13/2010CA2321268C Liquid crystal forms of cyclosporin
04/13/2010CA2189015C Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
04/13/2010CA2089229C Cd40cr receptor and ligands therefor
04/08/2010WO2010040096A2 Methods for the treatment of graft-versus-host disease
04/08/2010WO2010039924A2 Th1 vaccination priming for active immunotheraphy
04/08/2010WO2010039742A2 Methods to reduce b-helper t cells to treat autoimmune diseases
04/08/2010WO2010039563A2 Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens
04/08/2010WO2010039236A1 Compounds for inflammation and immune-related uses
04/08/2010WO2010039049A1 Method of modifying the immune response
04/08/2010WO2010039048A1 Compositions and methods for treatment of radiation exposure
04/08/2010WO2010038465A1 8-substituted isoquinoline derivative and use thereof
04/08/2010WO2010037878A1 Utilisation of nanoparticles of noble metals as immunomodulators and immunomodulator composition
04/08/2010WO2010037856A2 DYNACTIN-1/p150glued AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY AND A METHOD FOR IDENTIFYING TARGETABLE DISEASE-RELATED PROTEINS
04/08/2010WO2010037765A2 4-morpholino-pyrido[3,2-d]pyrimidines
04/08/2010WO2010037351A1 Peptide antagonist of interleukin-15 activity
04/08/2010WO2010037179A1 Anionic conjugates of glycosylated bacterial metabolite
04/08/2010WO2010011347A9 Clip inhibitors and methods of modulating immune function
04/08/2010WO2010009380A9 Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome
04/08/2010WO2010006172A3 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs
04/08/2010WO2009156092A3 Bi-and polycyclic substituted isoquinoline and isoquinoline derivatives as rho kinase inhibitors
04/08/2010WO2009075854A3 Effective quantitation of complex peptide mixtures in tissue samples and improved therapeutic methods
04/08/2010US20100087539 N'--3-amino-3-phenylpropeonic acid and the pharmaceutically acceptable derivatives thereof, a method for the production and the use thereof in the form of a medicinal agent
04/08/2010US20100087521 Biologically active complex
04/08/2010US20100087515 Ikk-beta serine-threonine protein kinase inhibitors
04/08/2010US20100087510 Novel Adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof
04/08/2010US20100087502 Indazoles Used To Treat Estrogen Receptor Beta Mediated Disorders
04/08/2010US20100087495 Phenyl derivatives and their use as immunomodulators
04/08/2010US20100087491 Polycyclic compounds
04/08/2010US20100087464 Protein kinase inhibitors and methods for using thereof
04/08/2010US20100087441 Prognostic Method
04/08/2010US20100087438 New Potassium Channel Blockers
04/08/2010US20100087437 Novel Potassium Channel Blockers
04/08/2010US20100087432 Pyrrole derivatives having crth2 receptor antagonist activity
04/08/2010US20100087430 Novel benzofuran potassium channel blockers and uses thereof
04/08/2010US20100087428 Novel Potassium Channel Blockers
04/08/2010US20100087366 Gh secretagogues and uses thereof
04/08/2010US20100086568 Modification of allergens
04/08/2010US20100086565 Vectors for expression of hml-2 polypeptides
04/08/2010US20100086562 Use of Platelet Glycopeptide IIIA Epitopes in the Treatment of Immune Thrombocytopenic Purpura
04/08/2010US20100086560 Chemokines as adjuvants of immune response
04/08/2010US20100086559 Polypeptide formulation
04/08/2010US20100086541 Regulation of autophagy pathway phosphorylation and uses thereof
04/08/2010US20100086539 Method and preparations for the diagnosis and therapy of multiple sclerosis and immune demyelinating polyneuropathy
04/08/2010US20100086538 Antibody Molecules Which Bind to Human IL-17
04/08/2010US20100086526 Nucleic acid constructs and methods for specific silencing of h19
04/08/2010CA2742550A1 4-morpholino-pyrido[3,2-d]pyrimidines
04/08/2010CA2739454A1 Methods for the treatment of graft-versus-host disease
04/08/2010CA2739321A1 Compounds for inflammation and immune-related uses
04/08/2010CA2739255A1 Th1 vaccination priming for active immunotheraphy
04/08/2010CA2739050A1 Antibodies against il-25
04/08/2010CA2738793A1 Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens
04/08/2010CA2738744A1 Peptide antagonist of interleukin-15 activity
04/08/2010CA2738660A1 Methods to reduce b-helper t cells to treat autoimmune diseases
04/08/2010CA2738622A1 Compositions and methods for treatment of radiation exposure
04/08/2010CA2738563A1 8-substituted isoquinoline derivatives and the use thereof
04/07/2010EP2172488A1 Material with immunogenicity
04/07/2010EP2172472A2 Aminophosphonic acid derivative, salt thereof and modulator of S1P receptor
04/07/2010EP2172457A2 Fredericamycin derivatives
04/07/2010EP2172453A1 COMPOUND HAVING 11 ß-HSD1 INHIBITORY ACTIVITY
04/07/2010EP2172222A2 Novel BLT2-mediated disease, BLT2-binding agent and compound
04/07/2010EP2172202A1 Prostaglandin derivative-containing aqueous liquid agent
04/07/2010EP2171060A2 Superagonistic anti-cd28 antibody
04/07/2010EP2170946A2 B7-dc variants
04/07/2010EP2170850A1 Novel dicarboxylic acid derivatives as s1p1 receptor agonists
04/07/2010EP2170842A1 Protein kinase inhibitors and methods for using thereof
04/07/2010EP2170809A2 Methods for the preparation and formulation of l-carnitine valproate salts
04/07/2010EP2170386A1 Use of intranasally administered pidotimod to enhance antigen-specific humoral and cell-mediated immune response
04/07/2010EP2170380A1 Capsid proteins and uses therefore
04/07/2010EP2170364A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection
04/07/2010EP2170361A2 Treatment and prevention of inflammatory diseases and autoimmune diseases
04/07/2010EP2170311A1 Compounds and methods for treating or preventing autoimmune diseases
04/07/2010EP1590047B1 Composition comprising lactobacilli or bifidobacteria and use thereof
04/07/2010EP1431275B1 Diaryl ether derivative, addition salt thereof, and immunosuppressant
04/07/2010CN101691575A Biosynthetic gene cluster of sanglifehrin
04/07/2010CN101691568A Method of producing edible immobilized active probiotics
04/07/2010CN101691405A Fusion antigen uses as vaccine
04/07/2010CN101690822A Medicament carrier for targeted medicament delivery on diseases related to macrophage and preparation method thereof
04/07/2010CN101690815A Novel use of dipeptidyl peptidase-iv inhibitor
04/07/2010CN101690813A Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease and preparation process thereof
04/07/2010CN101690812A Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease-infectious bursal disease and preparation process thereof
1 ... 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 ... 1172